Emile Voest
Directeur/Bestuurslid bij SANOFI
Actieve functies van Emile Voest
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SANOFI | Directeur/Bestuurslid | 03-05-2022 | - |
Independent Dir/Board Member | 03-05-2022 | - | |
Hartwig Medical Foundation | Directeur/Bestuurslid | 01-01-2015 | - |
Oprichter | 01-01-2015 | - | |
Center For Personalized Cancer Therapy | Directeur/Bestuurslid | 01-01-2010 | - |
Oprichter | 01-01-2010 | - | |
University of Utrecht | Corporate Officer/Principal | 01-01-1999 | - |
Loopbaan van Emile Voest
Eerdere bekende functies van Emile Voest
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 01-01-2020 |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Directeur/Bestuurslid | 01-01-2015 | 01-01-2020 |
Hubrecht Organoid Technology Foundation | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | 01-01-2016 |
Oprichter | 01-01-2013 | 01-01-2016 |
Opleiding van Emile Voest
University of Utrecht | Doctorate Degree |
Statistieken
Internationaal
Nederland | 5 |
Frankrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 4 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
Miscellaneous | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SANOFI | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Miscellaneous |
Hartwig Medical Foundation | |
Center For Personalized Cancer Therapy | |
Hubrecht Organoid Technology Foundation | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
- Beurs
- Insiders
- Emile Voest
- Ervaring